Allogeneic double‐negative T cell therapy for relapsed <scp>acute myeloid leukemia</scp> patients post <scp>allogeneic hematopoietic stem cell transplantation</scp>: A first‐in‐human phase I study

Baolin Tang, Xiaoyu Zhu, Siqi Cheng et al.|American Journal of Hematology|2022

Cited by 26